1 Daring to Make a Difference Company Presentation March 2020 『·revance Forward-Looking Statements / Safe Harbor / Market Data 2 This presentation contains forward-looking statements, including forward-statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to: financial metrics and outlook; the process and timing of, and ability to complete, current and anticipated future clinical development of our investigational product candidates, including anticip ...

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2019 Results Earnings Conference Call February 24, 2020 4:30 AM ET Company Participants Jeanie Herbert - Senior Director of Investor Relations and Corporate Communications Mark Foley - President, Chief Executive Officer Dustin Sjuts - Chief Commercial Officer of Aesthetics & Therapeutics Toby Schilke - Chief Financial Officer Abhay Joshi - Chief Operating Officer, President of R&D and Product Operations Conference Call Participants Annabel Samimy - Stifel Ken Cacc ...

Daring to Make a Difference 38th Annual JP Morgan Healthcare Conference Company Presentation January 16, 2020 Forward-Looking Statements / Safe Harbor / Market Data This presentation contains forward-looking statements, including forward-statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to: financial metrics, the process and timing of, and ability to complete, current and anticipated future clinical development of our investigational product candi ...

Daring to Make a Difference Investor presentation NASDAQ: RVNC NOVEMBER 2019 Forward-Looking Statements / Safe Harbor / Market Data This presentation contains forward-looking statements, including forward-statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to: financial metrics, the process and timing of, and ability to complete, current and anticipated future clinical development of our investigational product candidates, including anticipated near ...

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2019 Earnings Conference Call November 4, 2019 4:30 PM ET Company Participants Jeanie Herbert - Senior Director of IR & Corporate Communications Mark Foley - President & CEO Tobin Schilke - CFO & Principal Accounting Officer Abhay Joshi - COO Dustin Sjuts - Head of Commercial, Aesthetics & Therapeutics Conference Call Participants Annabel Samimy - Stifel David Amsellem - Piper Jaffray Jacob Hughes - Wells Fargo Stacy Ku - Cowen & Company Douglas Tsao - H.C. Wainwr ...

Daring to Make a Difference Investor presentation NASDAQ: RVNC OCTOBER 2019 2 Forward-Looking Statements / Safe Harbor / Market Data This presentation contains forward-looking statements, including forward-statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to: financial metrics, the process and timing of, and ability to complete, current and anticipated future clinical development of our investigational product candidates, including anticipated nea ...

The Next-Generation Neuromodulator is Here Investor Presentation | NASDAQ: RVNC S E P T E M B E R 2 0 1 9 Forward-Looking Statements / Safe Harbor / Market Data This presentation contains forward-looking statements, including statements related to: financial metrics, the process and timing of, and ability to complete, current and anticipated future clinical development of our investigational product candidates, including anticipated near-term milestones; our business strategy, goals, plans and prospects; th ...

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q2 2019 Results Earnings Conference Call August 5, 2019 4:30 PM ET Company Participants Jeanie Herbert - Senior Director of IR & Corporate Communications Daniel Browne - Co-Founder, President, CEO Tobin Schilke - CFO & Principal Accounting Officer Conference Call Participants Annabel Samimy - Stifel Ken Cacciatore - Cowen & Company Seamus Fernandez - Guggenheim David Amsellem - Piper Jaffray David Maris - Wells Fargo Tim Lugo - William Blair Douglas Tsao - H.C. Wainw ...